LLY

Eli Lilly and Company ·NYSE·Healthcare
1,220.42 live · 2026-08-12 15:59
84.5%
Brown Bear Score
92.2%
Business Conviction Score
63.8%
Position Health Score
31.5%
Chase Risk
Daily closes

Daily closes · 1Y (252 sessions) · +90.8% · range 639.43–1,235.56

The Businesswhat the company reports

Business & cash flow

OCF / assets 14.9%
FCF / revenue 25.8%
Gross margin 83.4%
ROIC 38.4%
Forward P/E 26.0

This company does not report capital expenditure in the standard filing tag, so free cash flow cannot be derived and FCF/assets is not shown — common for asset managers, REITs, insurers and utilities. OCF/assets is shown instead, and it is the other measure Brown Bear's testing found to survive. Assets are from the latest annual filing (FY2025).

Price vs Earnings growth

Price has run ahead of forward EPS growth by 34.9pp

Confidence 95.0/100

Takeaway Price has moved further than forward earnings growth currently justifies — worth weighing against the rest of the entry case.

Reported earnings

Next report 2026-10-29 · consensus EPS 9.81

Q2 23 revenue: 8.31bnQ2 23 net income: 1.76bnQ2 23 EPS: 1.95Q3 23 revenue: 9.50bnQ3 23 net income: -57.40mQ3 23 EPS: -0.06Q3 23Q4 23 revenue: 9.35bnQ4 23 net income: 2.19bnQ4 23 EPS: 2.42Q1 24 revenue: 8.77bnQ1 24 net income: 2.24bnQ1 24 EPS: 2.48Q1 24Q2 24 revenue: 11.30bnQ2 24 net income: 2.97bnQ2 24 EPS: 3.28Q3 24 revenue: 11.44bnQ3 24 net income: 970.30mQ3 24 EPS: 1.07Q3 24Q4 24 revenue: 13.53bnQ4 24 net income: 4.41bnQ4 24 EPS: 4.88Q1 25 revenue: 12.73bnQ1 25 net income: 2.76bnQ1 25 EPS: 3.06Q1 25Q2 25 revenue: 15.56bnQ2 25 net income: 5.66bnQ2 25 EPS: 6.29Q3 25 revenue: 17.60bnQ3 25 net income: 5.58bnQ3 25 EPS: 6.21Q3 25Q4 25 revenue: 19.29bnQ4 25 net income: 6.64bnQ4 25 EPS: 7.38Q1 26 revenue: 19.80bnQ1 26 net income: 7.40bnQ1 26 EPS: 8.26Q1 26

Revenue Net incomeEPS (GAAP) (-0.06–8.26, own scale) Derived Q4

12 quarters to Q1 26. Revenue and net income share one scale, so the gap between them is the margin. The baseline is zero — bars below it are losses. The line is GAAP EPS — it spans every quarter shown, where the reported figure only goes back as far as the consensus feed does.

Quarter endingRevenueYoY Net incomeEPS (GAAP) EPS reportedvs consensus Filed
2026-03-31 19.80bn +55.5% 7.40bn 8.26 8.55 +27.0% 2026-04-30
2025-12-31 (derived) 19.29bn +42.6% 6.64bn 7.38 7.54 +11.9% 2026-02-12
2025-09-30 17.60bn +53.9% 5.58bn 6.21 7.02 +22.0% 2025-10-30
2025-06-30 15.56bn +37.6% 5.66bn 6.29 2025-08-07

Earnings response

Typical move around a filing ±8.2%
On an ordinary two days ±1.5% — filings move it 5.3× as much
Direction 7 up, 4 down over 11 filings
Revenue change and price reaction, by quarter
Q3 22 revenue +2.5% year on yearQ3 22 filed 2022-11-01: price -2.0%Q1 23 revenue -10.9% year on yearQ1 23 filed 2023-04-27: price +5.2%Q1 23Q2 23 revenue +28.1% year on yearQ2 23 filed 2023-08-08: price +15.9%Q3 23 revenue +36.8% year on yearQ3 23 filed 2023-11-02: price +2.4%Q3 23Q1 24 revenue +26.0% year on yearQ1 24 filed 2024-04-30: price +5.4%Q2 24 revenue +36.0% year on yearQ2 24 filed 2024-08-08: price +15.5%Q2 24Q3 24 revenue +20.4% year on yearQ3 24 filed 2024-10-30: price -8.2%Q1 25 revenue +45.2% year on yearQ1 25 filed 2025-05-01: price -8.4%Q1 25Q2 25 revenue +37.6% year on yearQ2 25 filed 2025-08-07: price -16.2%Q3 25 revenue +53.9% year on yearQ3 25 filed 2025-10-30: price +6.1%Q3 25Q1 26 revenue +55.5% year on yearQ1 26 filed 2026-04-30: price +13.2%

Revenue up year on year Revenue down Price move around the filing separate scales — a crossing means nothing

Quarter endingFiledRevenue YoY Move around filingNext 20 sessions vs SPY
2026-03-31 2026-04-30 +55.5% +13.2% +7.3%
2025-09-30 2025-10-30 +53.9% +6.1% +23.0%
2025-06-30 2025-08-07 +37.6% -16.2% +16.5%
2025-03-31 2025-05-01 +45.2% -8.4% -13.7%

Share count

Diluted shares over time

Diluted shares Return since the previous filing

Direction Flat — little net change
Diluted shares 895.9M as at 2026-03-31
Change over 1 year -0.5%
Change over 3 years -0.8%
Public float $807.89bn as at 2025-06-30 (10-K)

The Pricewhat the chart is doingTop ↑

Price Levels

StrategyCurrent Price Reasonable
Reference band 1,201.98 — 1,232.48
Protective stop 1,124.39 (Atr, 7.6% risk)
Support 1,136.70 (2 touches, 7.4% away)
Resistance 1,239.82 (1.6% away)

Takeaway The shares are nearer the ceiling than the floor: about 1.6% below 1,239.82, where sellers have turned up before, and 7.4% above 1,136.70, where buyers have stepped in before. That floor has held 2 times, which is how it was spotted. If someone bought at today's price and sold if it dropped through the level below, they would be about 7.6% out of pocket. That is all this figure means — an illustration of the risk, not a price to sell at.

Levels are computed from price structure. They describe where the engine locates support and extension — they are not targets, and not advice.

Ichimoku Cloud (Adaptive)

Daily cloudPrice ABOVE the cloud | periods 5/15/30 (58% of classic 9/26/52)
LinesTenkan/Kijun BULL (fresh up cross, 2d ago) | cloud twist BEAR
Cloud eventFresh up breakout 4d ago
Cloud thickness8% percentile (thin — little structure to fight through)
Chikou spanAbove price from 26 periods ago
Weekly cloudPrice ABOVE the weekly cloud (context only, not scored)

Takeaway The stock is trading above its cloud — a shaded band drawn from several of its own moving averages, currently 1,176.24 to 1,179.30. Being above it means the medium-term picture is pointing upwards, and that band is the first place the stock has recent support if it slips back. Its shorter-term averages agree with that.

Trailing returns

21 days +5.9%
63 days +23.3%
126 days +19.1%
252 days +92.1%
Below 252d high1.2%

Trend context

PositionFar above trend
ExtensionExtremely extended
Trend slopeFlat
Direction of travelConverging back to trend

Takeaway Extreme upside extension above Kalman fair trend; entry risk is elevated.

Volatility

State In a squeeze
Current band width10.9% of price
Recent tightest8.7% (9 sessions ago, narrower than 89.0% of its history)
Expansion since1.25×
Band 1,115.61 — 1,244.32

Takeaway Lately this share price has been swinging around inside a range roughly 11% wide, and it recently went unusually quiet — calmer than it has been 89% of the time. When a stock goes quiet like this, its next move tends to look big by comparison. But quiet says nothing about which way it will go: Brown Bear tested calm-before-a-move as a reason to buy, and it did not work.

Historical trends

0255075100Share price 1,115.68–1,231.942026-07-032026-08-12
Position Health Business Conviction Share price

History begins when the site started recording, not when the company listed, so a short line means a short record and nothing more.

Who's Tradingthe flow behind the priceTop ↑

Insider activity

ActivityInsider selling
Buy filings0
Sell filings2
Shares sold7,000
Value sold$8.3m
Latest sell2026-08-10
FiledInsiderSharesValue
2026-08-10 Sold Zakrowski Donald ASVP, Finance, & CAO 2,000 $2,370,020
2026-08-07 Sold Hakim AnatEVP, GC & Secretary 5,000 $5,950,000

Open-market Form 4 purchases and sales over the last 75 days, read from SEC EDGAR Form 4. Grants, option exercises, gifts and shares withheld for tax are excluded — they are compensation mechanics, not a decision to buy or sell. Reported Form 4 activity. Brown Bear tested insider cluster-buying as a return signal and rejected it as era-unstable; shown as fact, not signal.

Volume confirmation

Volume-price trend Above its signal line
Confirmation Marginal

No absorption or distribution event in the recent window.

Takeaway Slightly more shares change hands on rising days than on falling ones, but the gap is too small to read anything into.

Options Positioning

No binary-event flag

LLY: no binary-event flag. Near IV 33%, far IV 34% (ratio 0.99), implied move 4.2%.

Implied volatility 33% near (9d) · 34% far (65d)
Term structure 0.99× near/far
Historical volatility 36%
Implied vs historical 0.93×
Implied move ±4.2% by 2026-08-21
Implied move vs ATR 0.47×
Skew Flat (1.10×)
Call wall 1,300.00 (+7.9% away)
Put wall 520.00 (-56.8% away)
Gamma pin 1,300.00

Takeaway Insuring against a move in this stock costs less for the next few weeks than for the next few months, which is the normal state of affairs and suggests no particular date is worrying anyone. Options traders are positioned for a move of around 4.2% in either direction by 2026-08-21.

Chain as at 2026-08-12. This is a risk read on whether a specific event is being priced — not a directional view.

Context & Methodthe record, and how it was builtTop ↑

Relative Rotation

ImprovingLeadingLaggingWeakeningvs sectorvs SPYsector vs SPYRS-Ratio →RS-Momentum →

Mixed Rotation Phase

Rotation health 65.5/100; Positive Rotation.

Rotation health 65.5
Rotation strength 68.5
LegQuadrantRS-RatioRS-Mom
Stock vs sector Improving 94.7 117.3
Stock vs SPY Improving 90.6 110.8
Sector vs SPY Improving 86.4 102.1

Direction of travel: North-East / strengthening leadership

Position only. Brown Bear's RRG redesign programme is closed — five constructions, none beat an appropriate null — so this section describes where the name sits, and is not a signal.

News Headlines

  1. Loading headlines\u2026

Headlines are supplied by third-party feeds and are not written, ranked or interpreted by Brown Bear. They feed no score on this page.

Detailed Scoring

Positive signals

  • Piotroski F-score 5/9 (+10.0)
  • Altman Z-score 9.53 (+10.0)
  • Insider conviction score (+5.0)
  • Gross margin quality: 83.4% (+22.0)
  • ROIC quality: 38.4% (+28.7)
  • FCF margin quality: 25.8% (+17.2)
  • Gross margin improving by 2.1 pts (+2.0)
  • ROIC improving by 4.6 pts (+2.0)
  • FCF margin improving by 6.2 pts (+4.0)
  • High earnings quality (accrual ratio 0.034) (+2.0)
  • Track 1: MACD histogram state (4.08) (+8.0)
  • Track 1: relative strength trend improving (+5.0)
  • Track 1: 20-day momentum acceleration 0.03 (+3.0)
  • Track 1: bullish DI spread 12.2 (+3.0)
  • Track 1: ADX 16.1 and rising (+2.0)
  • Track 1: relative momentum rank 0.94 (+5.0)
  • Track 1: EMA20 reclaim distance 3.1% (+5.5)
  • Track 1: EMA20 slope improving 1.5% (+3.8)
  • Track 1: MACD histogram acceleration 12.16 (+10.0)
  • Track 1: positive MACD regime (+3.0)
  • Track 1: MACD line/signal repair quality (+10.0)
  • Track 1: MACD slope improving (+3.0)
  • Track 1: RSI recovery 55.9, 5-day change +5.8 (+3.4)
  • Track 1: VPT strength 0.11 (+2.1)
  • Track 1: price above EMA50 by 6.0% (+3.8)
  • Track 1: EMA50 slope improving 1.2% (+2.5)
  • Track 1: Bollinger position 0.81 (+1.5)

Negative signals

  • Track 1: weak volume confirmation (0.56x average)

Chase risk is not elevated for this name, so extension penalties are omitted from the negative signals above.